IRIDEX Net Income
| IRIX Stock | USD 1.46 0.03 2.10% |
As of the 8th of February, IRIDEX retains the Market Risk Adjusted Performance of 0.515, semi deviation of 4.61, and Risk Adjusted Performance of 0.0979. IRIDEX technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
IRIDEX Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.6018 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -8 M | -7.6 M | |
| Net Loss | -6.8 M | -6.5 M | |
| Net Loss | -8 M | -7.6 M | |
| Net Loss | (0.62) | (0.59) | |
| Net Income Per E B T | 0.91 | 0.78 |
IRIDEX | Net Income | Build AI portfolio with IRIDEX Stock |
The evolution of Net Income for IRIDEX provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how IRIDEX compares to historical norms and industry peers.
Latest IRIDEX's Net Income Growth Pattern
Below is the plot of the Net Income of IRIDEX over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in IRIDEX financial statement analysis. It represents the amount of money remaining after all of IRIDEX operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is IRIDEX's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IRIDEX's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (8.91 M) | 10 Years Trend |
|
Net Income |
| Timeline |
IRIDEX Net Income Regression Statistics
| Arithmetic Mean | (4,801,944) | |
| Coefficient Of Variation | (136.37) | |
| Mean Deviation | 5,482,666 | |
| Median | (7,547,000) | |
| Standard Deviation | 6,548,226 | |
| Sample Variance | 42.9T | |
| Range | 22.9M | |
| R-Value | (0.64) | |
| Mean Square Error | 27.2T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | (826,116) | |
| Total Sum of Squares | 686.1T |
IRIDEX Net Income History
Other Fundumenentals of IRIDEX
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
IRIDEX Net Income component correlations
IRIDEX Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for IRIDEX is extremely important. It helps to project a fair market value of IRIDEX Stock properly, considering its historical fundamentals such as Net Income. Since IRIDEX's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IRIDEX's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IRIDEX's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRIDEX. Market participants price IRIDEX higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive IRIDEX assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth 0.078 | Return On Assets | Return On Equity |
IRIDEX's market price often diverges from its book value, the accounting figure shown on IRIDEX's balance sheet. Smart investors calculate IRIDEX's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since IRIDEX's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IRIDEX's value and its price as these two are different measures arrived at by different means. Investors typically determine if IRIDEX is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRIDEX's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IRIDEX 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IRIDEX's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IRIDEX.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in IRIDEX on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding IRIDEX or generate 0.0% return on investment in IRIDEX over 90 days. IRIDEX is related to or competes with Adagio Medical, Envoy Medical, Pulmatrix, Vivos Therapeutics, Aspire BioPharma, Allurion Technologies, and Palisade Bio. IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices... More
IRIDEX Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IRIDEX's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IRIDEX upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.19 | |||
| Information Ratio | 0.0949 | |||
| Maximum Drawdown | 35.45 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.89 |
IRIDEX Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRIDEX's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IRIDEX's standard deviation. In reality, there are many statistical measures that can use IRIDEX historical prices to predict the future IRIDEX's volatility.| Risk Adjusted Performance | 0.0979 | |||
| Jensen Alpha | 0.5152 | |||
| Total Risk Alpha | 0.0573 | |||
| Sortino Ratio | 0.1024 | |||
| Treynor Ratio | 0.505 |
IRIDEX February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0979 | |||
| Market Risk Adjusted Performance | 0.515 | |||
| Mean Deviation | 3.47 | |||
| Semi Deviation | 4.61 | |||
| Downside Deviation | 5.19 | |||
| Coefficient Of Variation | 901.96 | |||
| Standard Deviation | 5.61 | |||
| Variance | 31.45 | |||
| Information Ratio | 0.0949 | |||
| Jensen Alpha | 0.5152 | |||
| Total Risk Alpha | 0.0573 | |||
| Sortino Ratio | 0.1024 | |||
| Treynor Ratio | 0.505 | |||
| Maximum Drawdown | 35.45 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.89 | |||
| Downside Variance | 26.98 | |||
| Semi Variance | 21.28 | |||
| Expected Short fall | (4.09) | |||
| Skewness | 1.24 | |||
| Kurtosis | 11.18 |
IRIDEX Backtested Returns
IRIDEX appears to be dangerous, given 3 months investment horizon. IRIDEX holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11 % return per unit of risk over the last 3 months. By analyzing IRIDEX's technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please utilize IRIDEX's Risk Adjusted Performance of 0.0979, market risk adjusted performance of 0.515, and Semi Deviation of 4.61 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, IRIDEX holds a performance score of 8. The company retains a Market Volatility (i.e., Beta) of 1.21, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, IRIDEX will likely underperform. Please check IRIDEX's treynor ratio, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether IRIDEX's current trending patterns will revert.
Auto-correlation | -0.21 |
Weak reverse predictability
IRIDEX has weak reverse predictability. Overlapping area represents the amount of predictability between IRIDEX time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IRIDEX price movement. The serial correlation of -0.21 indicates that over 21.0% of current IRIDEX price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
IRIDEX Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, IRIDEX reported net income of (8.91 Million). This is 102.61% lower than that of the Health Care Equipment & Supplies sector and 103.74% lower than that of the Health Care industry. The net income for all United States stocks is 101.56% higher than that of the company.
IRIDEX Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IRIDEX's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IRIDEX could also be used in its relative valuation, which is a method of valuing IRIDEX by comparing valuation metrics of similar companies.IRIDEX is currently under evaluation in net income category among its peers.
IRIDEX Institutional Holders
Institutional Holdings refers to the ownership stake in IRIDEX that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of IRIDEX's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing IRIDEX's value.| Shares | Citadel Advisors Llc | 2025-06-30 | 31.2 K | Xtx Topco Ltd | 2025-06-30 | 25.2 K | Northern Trust Corp | 2025-06-30 | 24.9 K | Blackrock Inc | 2025-06-30 | 20.3 K | Hightower Advisors, Llc | 2025-06-30 | 10 K | Tower Research Capital Llc | 2025-06-30 | 5.5 K | Group One Trading, Lp | 2025-06-30 | 1.1 K | Simplex Trading, Llc | 2025-03-31 | 125 | Bank Of America Corp | 2025-06-30 | 123 | Paragon Assoc & Paragon Assoc Ii Jv | 2025-06-30 | 1000 K | Vanguard Group Inc | 2025-06-30 | 585.8 K |
IRIDEX Fundamentals
| Return On Equity | -1.39 | ||||
| Return On Asset | -0.0653 | ||||
| Profit Margin | (0.10) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 30.48 M | ||||
| Shares Outstanding | 16.99 M | ||||
| Shares Owned By Insiders | 27.50 % | ||||
| Shares Owned By Institutions | 15.39 % | ||||
| Number Of Shares Shorted | 270.16 K | ||||
| Price To Earning | (6.30) X | ||||
| Price To Book | 331.20 X | ||||
| Price To Sales | 0.50 X | ||||
| Revenue | 48.67 M | ||||
| Gross Profit | 19.34 M | ||||
| EBITDA | (6.88 M) | ||||
| Net Income | (8.91 M) | ||||
| Cash And Equivalents | 17.97 M | ||||
| Cash Per Share | 1.12 X | ||||
| Total Debt | 4.64 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 3.19 X | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (7.29 M) | ||||
| Short Ratio | 4.99 X | ||||
| Earnings Per Share | (0.32) X | ||||
| Price To Earnings To Growth | (0.44) X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 93 | ||||
| Beta | 0.65 | ||||
| Market Capitalization | 15.08 M | ||||
| Total Asset | 29.14 M | ||||
| Retained Earnings | (88.01 M) | ||||
| Working Capital | 7 M | ||||
| Current Asset | 30.77 M | ||||
| Current Liabilities | 7.43 M | ||||
| Net Asset | 29.14 M |
About IRIDEX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IRIDEX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IRIDEX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IRIDEX based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for IRIDEX Stock Analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.